三维适形放疗与调强放疗在浸润型胸腺瘤术后的效果对比(4)
[10]Patel S，Macdonald OK，Naagda S，et al.Evaluation of the role of radiation therapy in the management of malignant thymoma[J].Int J Radiat Onocl Biol Phys，2012，82(5)：1797-1801.
[11]Forquer JA，Rong N，Fakiris AJ，et al.Postoperative radiotherapy after surgical resection of thymoma：differing roles in localized and regional disease[J].Int J Radiat Onocl Biol Phys，2010，76(2)：440-445.
[12]Graham MV，Purdy JA，Emami B，et al.Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small celllung cancer (NSCLC)[J].Int J Radiat Oncol Biol Phys，1999，45(2)：323-329.
[13]Tsujino K，Hirota S，Endo M，et al.Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer[J].Int J Radiat Oncol Biol Phys，2003，55(1)：110-115.
[14]Willner J，Jost A，Baier K，et al.A little to a lot or a lot to a little An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy[J].Strahlenther Onkol，2003，179(8)：548-556.
[15]Seppenwoolde Y，Lebesque JV，de Jaeger K，et al.Comparing different NTCP models that predict the incidence of radiation pneumonitis.Normal tissue complication probability[J].Int J Radiat Oncol Biol Phys，2003，55(3)：724-735.
[16]Gopal R，Ha CS，Tucker SL，et al.Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity[J].Cancer，2001，92(7)：1949-1958.
[17]Vogelius IS，Westerly DC，Cannon GM，et al.Intensity-modulated radiotherapy might increase pneumonitis risk relative to three-dimensional conformal radiotherapy in patients receiving combined chemotherapy and radiotherapy：a modeling study of dose dumping[J].Int J Radiat Oncol Biol Phys，2011，80(3)： 893-899.
[18]葛琴.放射性肺損伤的研究进展[J].肿瘤基础与临床，2014，27(1)：82-85.
(收稿日期：2017-08-22 本文编辑：许俊琴), 百拇医药(黄玉婷 朱铭 邹文蕙)
[11]Forquer JA，Rong N，Fakiris AJ，et al.Postoperative radiotherapy after surgical resection of thymoma：differing roles in localized and regional disease[J].Int J Radiat Onocl Biol Phys，2010，76(2)：440-445.
[12]Graham MV，Purdy JA，Emami B，et al.Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small celllung cancer (NSCLC)[J].Int J Radiat Oncol Biol Phys，1999，45(2)：323-329.
[13]Tsujino K，Hirota S，Endo M，et al.Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer[J].Int J Radiat Oncol Biol Phys，2003，55(1)：110-115.
[14]Willner J，Jost A，Baier K，et al.A little to a lot or a lot to a little An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy[J].Strahlenther Onkol，2003，179(8)：548-556.
[15]Seppenwoolde Y，Lebesque JV，de Jaeger K，et al.Comparing different NTCP models that predict the incidence of radiation pneumonitis.Normal tissue complication probability[J].Int J Radiat Oncol Biol Phys，2003，55(3)：724-735.
[16]Gopal R，Ha CS，Tucker SL，et al.Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity[J].Cancer，2001，92(7)：1949-1958.
[17]Vogelius IS，Westerly DC，Cannon GM，et al.Intensity-modulated radiotherapy might increase pneumonitis risk relative to three-dimensional conformal radiotherapy in patients receiving combined chemotherapy and radiotherapy：a modeling study of dose dumping[J].Int J Radiat Oncol Biol Phys，2011，80(3)： 893-899.
[18]葛琴.放射性肺損伤的研究进展[J].肿瘤基础与临床，2014，27(1)：82-85.
(收稿日期：2017-08-22 本文编辑：许俊琴), 百拇医药(黄玉婷 朱铭 邹文蕙)